Gene · 11091
Papers2,554
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,554
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Extracellular vesicle-derived lncRNA-GC1 serves as a novel biomarker for predicting and monitoring the immunotherapeutic outcomes of patients with gastric cancer. | BMC Med | 2025 | 40866962 | PubTator, text mining | PubMed |
| Target-aware 3D molecular generation based on guided equivariant diffusion. | Nat Commun | 2025 | 40854901 | PubTator, text mining | PubMed |
| Cooperative Free Energy: Induced Protein-Protein Interactions and Cooperative Solvation in Ternary Complexes. | J Chem Theory Comput | 2025 | 40832906 | PubTator, text mining | PubMed |
| Emerging implications of N6-methyladenosine in prostate cancer progression and treatment. | Cell Death Discov | 2025 | 40830264 | PubTator, text mining | PubMed |
| Prognostic value of a circadian rhythm-related gene signature in breast cancer patients: A retrospective cohort study. | Medicine (Baltimore) | 2025 | 40826746 | PubTator, text mining | PubMed |
| Participation of host cell proteins in inclusion bodies of non-segmented RNA virus infected cells: a molecular insight. | Virol J | 2025 | 40826091 | PubTator, text mining | PubMed |
| Structural insights into lysine-mediated WIN site recognition reveal an alternative "AK" motif for WDR5 binding. | Biochem Biophys Res Commun | 2025 | 40773920 | PubTator, text mining | PubMed |
| RNA Epigenetics in Cancer: Current Knowledge and Therapeutic Implications. | MedComm (2020) | 2025 | 40761481 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| The value of acetylation reader YEATS2 in hepatocellular carcinoma management. | Sci Rep | 2025 | 40731114 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction-mediated metabolic remodeling of TCA cycle promotes Parkinson's disease through inhibition of H3K4me3 demethylation. | Cell Death Discov | 2025 | 40730642 | PubTator, text mining | PubMed |
| Isotopologues of a Metabolic Precursor for Selective N-15 and C-13 Histidine Labeling. | J Mol Biol | 2025 | 40669594 | PubTator, text mining | PubMed |
| KDM6A downregulation promotes tumor-prone cytokines expression in cancer-associated fibroblasts by activating enhancers. | Cell Death Dis | 2025 | 40659611 | PubTator, text mining | PubMed |
| Astragaloside IV Alleviates Ulcerative Colitis Progression by Inhibiting WDR5-Mediated ENO1 H3K4me3 Modification. | Kaohsiung J Med Sci | 2025 | 40586619 | PubTator, text mining | PubMed |
| KBG syndrome-associated protein ANKRD11 regulates SETD5 expression to modulate rRNA levels and translation. | iScience | 2025 | 40520101 | PubTator, text mining | PubMed |
| AARS1-mediated Osterix lactylation promotes its transcriptional activity during osteoblast differentiation. | Acta Histochem | 2025 | 40505545 | PubTator, text mining | PubMed |
| NMR-driven structure-based drug discovery by unveiling molecular interactions. | Commun Chem | 2025 | 40450181 | PubTator, text mining | PubMed |
| Aberrant WDR5 promotes the progression of cervical cancer through the YAP1- CTGF pathway. | Life Sci | 2025 | 40414554 | PubTator, text mining | PubMed |
| Discovery of Novel Inhibitors for WD Repeat-Containing Protein 5 (WDR5)-MYC Protein-Protein Interaction. | Chem Biol Drug Des | 2025 | 40395176 | PubTator, text mining | PubMed |
| Histone modifications and metabolic reprogramming in tumor-associated macrophages: a potential target of tumor immunotherapy. | Front Immunol | 2025 | 40375990 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11091/papers?page=5